.

Befinfer

Human recombinant beta 1-a Interferon

 

  • Composition
    Each prefilled syringe contains the following active pharmaceutical ingredient:
    Befinfer 6 MUI:
    6 MIU (22 µg) of Human recombinant beta-1a Interferon.
    Befinfer 12 MUI:
    12 MIU (44 µg) of Human recombinant beta-1a Interferon.
     

  • Indications
    Recombinant human beta-1a interferon is indicated for the treatment of relapsing-remitting Multiple Sclerosis with relapses.

  • Contraindications
    Hypersensitivity to the drug or to human albumin. It must be used with caution in patients with severe depressive disorders, epilepsy and in pregnant women.

  • Presentation
    Box containing 12 prefilled syringes.